Clinical

Dataset Information

0

Study of Radspherin in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPEC


ABSTRACT: This is a phase 1/2a open label study to evaluate the dose, safety, tolerability and efficacy of an IP α-emitting radionuclide therapy (Radspherin) in subjects with peritoneal carcinomatosis (PC) from colorectal carcinoma following complete CRS (cytoreduction score CC-0) and HIPEC. The study consists of three different cohorts: * Dose escalation cohorts * Repeated injection cohorts * Expansion cohort

DISEASE(S): Colorectal Carcinoma,Peritoneal Neoplasms,Carcinoma,Peritoneal Carcinoma,Colorectal Neoplasms

PROVIDER: 2288875 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2084383 | ecrin-mdr-crc
| PRJNA42771 | ENA
2022-02-22 | GSE189004 | GEO
2022-02-22 | GSE189168 | GEO
2024-02-20 | GSE232007 | GEO
2021-05-03 | PXD006191 | Pride
2022-02-22 | GSE189137 | GEO
2020-04-25 | GSE149320 | GEO
2022-06-27 | GSE202454 | GEO
2021-08-03 | GSE159314 | GEO